Bromide

Bromide

SCHEMBL5451607

CO[Si](OC)(OC)c1ccc(Cn2cc[n+](C3CCCCC3)c2)cc1.[Br-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5442079 0.98 CYP19A1 (0.31) —
SCHEMBL5444932 0.94 — —
Trifluoromethanesulfonic Acid SCHEMBL5450098 0.89 CHRM2 (0.31) —
Bromide SCHEMBL5446447 0.88 — —
Hydrochloric Acid SCHEMBL5448168 0.86 — —
SCHEMBL5441439 0.83 — —
Trifluoromethanesulfonic Acid SCHEMBL5451627 0.78 — —
Bromide SCHEMBL5442828 0.71 KDM4E (0.31) —
Bromide SCHEMBL5453342 0.70 MEN1 (0.31) —
Bromide SCHEMBL5439303 0.70 CYP19A1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021615-A1 Imidazolium salts that can be immobilized MERCK PATENT GMBH (DE) 2007-01-25 — — US claimed
CN-1835957-A Imidazolium salts that can be immobilized MERCK PATENT GMBH (DE) 2006-09-20 — — CN claimed
US-20070021615-A1 Imidazolium salts that can be immobilized MERCK PATENT GMBH (DE) 2007-01-25 — — US disclosed
CN-1835957-A Imidazolium salts that can be immobilized MERCK PATENT GMBH (DE) 2006-09-20 — — CN disclosed
Send feedback